IE35421B1 - Quinoxaline derivatives - Google Patents
Quinoxaline derivativesInfo
- Publication number
- IE35421B1 IE35421B1 IE848/71A IE84871A IE35421B1 IE 35421 B1 IE35421 B1 IE 35421B1 IE 848/71 A IE848/71 A IE 848/71A IE 84871 A IE84871 A IE 84871A IE 35421 B1 IE35421 B1 IE 35421B1
- Authority
- IE
- Ireland
- Prior art keywords
- together signify
- taken together
- june
- alkyl
- optionally substituted
- Prior art date
Links
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical group 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1015970 | 1970-07-06 | ||
CH820271 | 1971-06-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE35421L IE35421L (en) | 1971-12-06 |
IE35421B1 true IE35421B1 (en) | 1976-02-04 |
Family
ID=25702964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE848/71A IE35421B1 (en) | 1970-07-06 | 1971-07-02 | Quinoxaline derivatives |
Country Status (11)
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL273989A (enrdf_load_stackoverflow) * | 1958-07-10 | 1900-01-01 | ||
US3507870A (en) * | 1968-12-18 | 1970-04-21 | Pfizer & Co C | 1,4-disubstituted-1,2,3,4-tetrahydrophenazine-5,10-dioxides |
-
1971
- 1971-06-29 DE DE19712132175 patent/DE2132175A1/de active Pending
- 1971-06-30 GB GB3069171A patent/GB1351342A/en not_active Expired
- 1971-07-02 IE IE848/71A patent/IE35421B1/xx unknown
- 1971-07-02 IL IL37213A patent/IL37213A0/xx unknown
- 1971-07-05 FR FR7124430A patent/FR2100864B1/fr not_active Expired
- 1971-07-05 HU HUCI1136A patent/HU165503B/hu unknown
- 1971-07-05 BE BE769491A patent/BE769491A/xx unknown
- 1971-07-05 AT AT1009972A patent/AT312624B/de not_active IP Right Cessation
- 1971-07-05 ES ES392918A patent/ES392918A1/es not_active Expired
- 1971-07-05 NL NL7109266A patent/NL7109266A/xx unknown
- 1971-07-05 AT AT1009872A patent/AT317228B/de not_active IP Right Cessation
- 1971-07-06 AU AU30875/71A patent/AU3087571A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AT312624B (de) | 1974-01-10 |
IE35421L (en) | 1971-12-06 |
NL7109266A (enrdf_load_stackoverflow) | 1972-01-10 |
BE769491A (fr) | 1972-01-05 |
AT317228B (de) | 1974-08-26 |
HU165503B (enrdf_load_stackoverflow) | 1974-09-28 |
FR2100864A1 (enrdf_load_stackoverflow) | 1972-03-24 |
DE2132175A1 (de) | 1972-01-13 |
AU3087571A (en) | 1973-01-17 |
FR2100864B1 (enrdf_load_stackoverflow) | 1974-09-06 |
IL37213A0 (en) | 1971-10-20 |
GB1351342A (en) | 1974-04-24 |
ES392918A1 (es) | 1974-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES364421A1 (es) | Procedimiento de preparacion de nuevos derivados de la n-a-mino indolina sustituida. | |
FR2354338A1 (fr) | Acides n-phosphonomethylene-monoaminoalcane-mono- et polyphosphoniques et acides n-phosphonomethylene-diaminoalcane-polyphosphoniques, et leur preparation | |
GB1374979A (en) | 3,5-dioxopiperazine derivatives | |
FR2430418A1 (fr) | Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques | |
GB1148586A (en) | Improvements in or relating to anguidine derivatives | |
FR2397385A1 (fr) | Derives du resorcinol, leur preparation et leurs utilisations therapeutiques | |
IE35421B1 (en) | Quinoxaline derivatives | |
FR2442226A1 (fr) | Anilines substituees, leur preparation et leurs utilisations | |
GB1256723A (enrdf_load_stackoverflow) | ||
FR2391189A1 (fr) | Derives de la 2-aminotetraline, leur preparation et leurs utilisations therapeutiques | |
GB1363658A (en) | Benzobicycloalkane compounds | |
ES374291A1 (es) | Un procedimiento para la preparacion de compuestos de 6,7- diaciloxi-tetrahidroisoquinoleinas. | |
FR2375223A1 (fr) | 1,2,6-thiadiazinones, leur preparation et leurs utilisations | |
FR2401922A1 (fr) | Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques | |
FR2372792A1 (fr) | Aminoalcoxybenzenes, leur preparation et leurs utilisations therapeutiques | |
FR2372164A1 (fr) | Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques | |
FR2433516A1 (fr) | Pyridoxines, leur preparation et leurs utilisations therapeutiques | |
FR2361393A1 (fr) | (2-azabicyclo (2.2.2)octane-2-yl) diphenylalcanones et derives, leur preparation et leurs utilisations therapeutiques, notamment comme anti-diarrheiques | |
FR2433553A1 (fr) | Resines de polyesters insatures, non inhibees par l'oxygene de l'air, leur preparation et leurs utilisations | |
GB1315355A (en) | Benzotriazole derivatives | |
FR2395989A1 (fr) | Derives diphenyle, leur preparation et leurs utilisations therapeutiques | |
FR2390435A1 (fr) | Thiobenzylpyrimidines, leur preparation et leurs utilisations therapeutiques | |
GB1353511A (en) | Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity | |
ES273933A1 (es) | Procedimiento para la producciën de sales de pirimidina | |
IE35223B1 (en) | Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones |